Northwest Pharmacy Research entered the industry of Commercial Medical Research in 1994 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 5416111, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Sam Deliganis, President by calling (206) 542-6873 during business hours. You can also write to the business’ Single Location at 1011 Nw 190th St, Seattle, Washington WA 98177. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Northwest Pharmacy Research |
Representative: | Sam Deliganis, President |
Place of Business: | 1011 Nw 190th St, Seattle, WA 98177 |
Contact Number: | (206) 542-6873 |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 5416111 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1994 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Northwest Pharmacy Research is a company operating from King, Washington providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1994 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 5416111 as Commercial Medical Research.
With a current employee count of 1 to 4, Northwest Pharmacy Research has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Sam Deliganis, President at (206) 542-6873 for related queries, or to locate its Single Location using the coordinates 47.766818,-122.370276.
The Single Location can also be found at the street address 1011 Nw 190th St in Seattle, Washington 98177 and can be engaged online through the company website at , the company Twitter , and Facebook page .